{"id":464724,"date":"2024-10-20T10:36:32","date_gmt":"2024-10-20T10:36:32","guid":{"rendered":"https:\/\/pdfstandards.shop\/product\/uncategorized\/bs-en-iso-11979-102018-2\/"},"modified":"2024-10-26T19:33:31","modified_gmt":"2024-10-26T19:33:31","slug":"bs-en-iso-11979-102018-2","status":"publish","type":"product","link":"https:\/\/pdfstandards.shop\/product\/publishers\/bsi\/bs-en-iso-11979-102018-2\/","title":{"rendered":"BS EN ISO 11979-10:2018"},"content":{"rendered":"
This document specifies requirements for any intraocular lenses to be implanted in the anterior segment of the eye with the primary indication to modify its refractive power.<\/p>\n
There are three main categories of phakic intraocular lenses depending on the optical design:<\/p>\n
Phakic monofocal (PIOL);<\/p>\n<\/li>\n
Phakic multifocal (PMIOL); and<\/p>\n<\/li>\n
Phakic toric (PTIOL).<\/p>\n<\/li>\n<\/ol>\n
Each of these categories is further designated for implantation in either the anterior or posterior chamber of the anterior segment of the eye.<\/p>\n
The basic phakic IOL requirements apply to all the types. Additional requirements apply to PMIOL and PTIOL designs.<\/p>\n
This document addresses specific clinical requirements for phakic IOLs that are not addressed in the other parts of ISO 11979.<\/p>\n
PDF Pages<\/th>\n | PDF Title<\/th>\n<\/tr>\n | ||||||
---|---|---|---|---|---|---|---|
2<\/td>\n | National foreword <\/td>\n<\/tr>\n | ||||||
4<\/td>\n | European foreword <\/td>\n<\/tr>\n | ||||||
6<\/td>\n | Foreword <\/td>\n<\/tr>\n | ||||||
7<\/td>\n | Introduction <\/td>\n<\/tr>\n | ||||||
9<\/td>\n | 1 Scope 2 Normative references <\/td>\n<\/tr>\n | ||||||
10<\/td>\n | 3 Terms, definitions and abbreviated terms 3.1 Terms and definitions 3.2 Abbreviated terms 4 Optical requirements 5 Mechanical requirements 6 Biocompatibility requirements 7 Shelf-life and transport stability requirements 8 Fundamental requirements <\/td>\n<\/tr>\n | ||||||
11<\/td>\n | 9 Justification for a clinical investigation 10 General clinical requirements 10.1 General 10.2 Design of a clinical investigation 10.2.1 Requirements for all types of phakic IOLs 10.2.2 Additional requirements for PTIOLs <\/td>\n<\/tr>\n | ||||||
12<\/td>\n | 10.2.3 Additional requirements for PMIOLs 10.3 Characteristics 10.3.1 General 10.3.2 Characteristics applying to the clinical evaluations for all types of phakic IOLs <\/td>\n<\/tr>\n | ||||||
13<\/td>\n | 10.3.3 Additional characteristics applying to PTIOLs 10.3.4 Additional characteristics applying to PMIOLs 10.4 Duration of the investigation 10.5 Enrolment 10.6 Bilateral implantation <\/td>\n<\/tr>\n | ||||||
14<\/td>\n | 10.7 Surgical technique 10.8 Examination and treatment of subjects 10.9 Adverse events reports 10.10 Inclusion and exclusion criteria 10.10.1 General criteria for all phakic IOLs <\/td>\n<\/tr>\n | ||||||
17<\/td>\n | 10.10.2 Additional criteria for PTIOLs 10.10.3 Additional criteria for multifocal IOLs 11 Information supplied by the manufacturer <\/td>\n<\/tr>\n | ||||||
18<\/td>\n | Annex A (informative) Elements in a phakic IOL clinical investigation <\/td>\n<\/tr>\n | ||||||
24<\/td>\n | Annex B (informative) Statistical methods and sample size calculations <\/td>\n<\/tr>\n | ||||||
25<\/td>\n | Bibliography <\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":" Ophthalmic implants. Intraocular lenses – Clinical investigations of intraocular lenses for correction of ametropia in phakic eyes<\/b><\/p>\n |